While North America and Europe currently represent the primary revenue generators for the Wilson's Disease (WD) market, the Asia-Pacific (APAC) region is rapidly emerging as the key engine for future growth and volume expansion. This transformation is underpinned by several compelling factors. First and foremost is the sheer population density; although WD prevalence is relatively uniform...